HOME   Cart(0)   Quotation   About-Us Policy PDFs Standard-List
www.ChineseStandard.net Database: 189760 (18 Oct 2025)

GB 16397-2011 English PDF

US$199.00 · In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
GB 16397-2011: Effect judging for preventive measures of Kaschin-Beck disease
Status: Obsolete

GB 16397: Evolution and historical versions

Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusPDF
GB 16397-2011English199 Add to Cart 3 days [Need to translate] Effect judging for preventive measures of Kaschin-Beck disease Obsolete GB 16397-2011
GB 16397-1996English199 Add to Cart 2 days [Need to translate] Judging criteria of preventive effect on kashin-Beck disease Obsolete GB 16397-1996

PDF similar to GB 16397-2011


Standard similar to GB 16397-2011

GBZ 20   GBZ 57   AQ 4273   GB/T 19380   GB 15976   GB 16395   

Basic data

Standard ID GB 16397-2011 (GB16397-2011)
Description (Translated English) Effect judging for preventive measures of Kaschin-Beck disease
Sector / Industry National Standard
Classification of Chinese Standard C61
Classification of International Standard 11.020
Word Count Estimation 6,632
Date of Issue 2011-12-30
Date of Implementation 2012-02-01
Older Standard (superseded by this standard) GB 16397-1996
Quoted Standard GB 16395; WS/T 207
Regulation (derived from) Announcement of Newly Approved National Standards No. 23 of 2011
Issuing agency(ies) General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Standardization Administration of the People's Republic of China
Summary This Chinese standard specifies the Kashin-Beck disease control measures in effect against the top decision index. This standard applies to a variety of Kashin-Beck disease endemic determine the effect of prevention and control measures.

GB 16397-2011: Effect judging for preventive measures of Kaschin-Beck disease

---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
Effect judging for preventive measures of Kaschin-Beck disease ICS 11.020 C61 National Standards of People's Republic of China Replacing GB 16397-1996 Kashin-Beck disease prevention and control measures determining effect Issued on. 2011-12-30 2012-02-01 implementation People's Republic of China Ministry of Health Standardization Administration of China released

Foreword

All technical contents of this standard is mandatory. This standard was drafted in accordance with GB/T 1.1-2009 given rules. This standard replaces GB 16397-1996 "KBD preventive effect on the determination." This standard and GB 16397-1996 comparison, the main changes are as follows. --- Increasing the terms and definitions; --- The control effects of prevention and control measures to effect; --- Remove the original standard "invalid" criteria in the "early"; --- No increase Ⅱ ° and no more cases have occurred early epiphyseal closure and triad cases and effective in determining standards; --- The observation period to three years; --- Increase in Appendix A. This standard is proposed and administered by the People's Republic of China Ministry of Health. This standard by the People's Republic of China Ministry of Health is responsible for interpretation. This standard was drafted. CDC Sichuan Endemic Disease Prevention and Control, Chinese Center for Disease Control of Endemic Diseases Control Center, Xi'an Jiaotong University, Jilin Institute of Endemic Diseases Prevention second. The main drafters of this standard. Deng Jiayun, Lifu Zhong, Liu Yun from Guo Xiong, ZHANG Xue-ying, Huang Hui. This standard replaces the standards previously issued as follows. --- GB 16397-1996. Kashin-Beck disease prevention and control measures determining effect

1 Scope

This standard specifies the Kashin-Beck disease prevention and control measures to effect the determination index. This standard applies to all kinds of prevention and control measures the effect of KBD endemic area determined.

2 Normative references

The following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein Member. For undated references, the latest edition (including any amendments) applies to this document. GB 16395 KBD endemic and criteria for the classification determination WS/T 207 KBD diagnosis

3 Terms and Definitions

The following terms and definitions apply to this document. 3.1 KBD precautions preventionmeasuresofKaschin-Beckdisease According to Kashin-Beck disease etiology of the latest results, for the cause of a chain link or more aspects of the blockade measures. 3.2 Triad triad X-ray film examination anteroposterior hand, metaphyseal bone end, the epiphysis, the carpal four parts, the three parts of KBD X-ray findings. Criterion 4 effect 4.1 Markedly In accordance with the requirements of Appendix A, and after implementing preventive measures to ward three years, it should also have the following two can be judged to have a significant effect (Jane He said markedly). a) observation of the original population without clinical Ⅰ of new cases and over; b) the observation of the population without KBD X-ray-positive cases. 4.2 Effective In accordance with the requirements of Appendix A, and after implementing preventive measures to ward three years, it should also have the following two can be determined to be valid. a) the original observation group Ⅰ clinical incidence of ≤2%, and no more cases occurred and Ⅱ degree; b) the observed X-ray positive rate of population ≤10% and the positive rate of bone ends ≤3%, and no early epiphyseal closure and triad cases. 4.3 Invalid In accordance with the requirements of Appendix A, and after implementing preventive measures to ward three years, with the following one, could be judged as invalid. a) the original population was observed in clinical Ⅰ degree or higher incidence > 2%; b) the crowd observed X-ray positive rate of > 10%, or bone-side positive rate > 3%.

Appendix A

(Normative) Kashin-Beck Disease Prevention in judgment conditions require A.1 observation ward selection Determined in accordance with GB 16395 wards, select the active disease severity index > Ward 50 of a village or several. Such as the condition level of activity No index > 50 Ward village, you can choose the degree of active disease in the index between 12 to 50 wards village one or more disease refers to the level of activity Calculation formula, see formula (A.1). Active disease severity index = Metaphyseal lesion detection Listings Number of subjects Metaphyseal lesions, "", "" total detection number æ Metaphyseal lesions detected total number × 100 (A.1) A.2 crowd observe conditions and counting Continuous residence in the ward for six months or more, and the local drinking water and eating local food for children age 7 to 9 years of age, the number of not less than 100 people observed the end dropout rate does not exceed 10%. A.3 observe the health status of populations Observe the initial stage, X-ray examination no right anteroposterior KBD change. A.4 observation period From March to April each year to conduct a clinical observation and X-ray film, observed for 3 consecutive years. A.5 X-ray film site Hand radiographs (including wrist). A.6 X line case diagnosis Specific diagnostic methods, see WS/T 207. A.7 establish reasonable control In the same ward, select the sex, age, the number of people observe the same as the control group.

Tips & Frequently Asked Questions:

Question 1: How long will the true-PDF of GB 16397-2011_English be delivered?

Answer: Upon your order, we will start to translate GB 16397-2011_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time.

Question 2: Can I share the purchased PDF of GB 16397-2011_English with my colleagues?

Answer: Yes. The purchased PDF of GB 16397-2011_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.

Question 3: Does the price include tax/VAT?

Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countries

Question 4: Do you accept my currency other than USD?

Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.

Question 5: Should I purchase the latest version GB 16397-2011?

Answer: Yes. Unless special scenarios such as technical constraints or academic study, you should always prioritize to purchase the latest version GB 16397-2011 even if the enforcement date is in future. Complying with the latest version means that, by default, it also complies with all the earlier versions, technically.